Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897234 · ClinicalTrials.gov registry record
Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 84
- Enrollment target
NCT00897234: Completed study, sponsored by University of Minnesota.
NCT00897234 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897234 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples from patients with non-small cell lung cancer and from healthy volunteers.
Primary Outcome
Measure plasma CD levels in patients with non-small cell lung cancer and non-smoker healthy controls using mass spectrometry.
Interventions
- OTHER Mass Spectrometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-10 |
What the finished NCT00897234 record still lists
NCT00897234 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Mass Spectrometry is the first listed.
NCT00897234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897234 about?
NCT00897234 is a clinical study titled "Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers". RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples from patients with non-small cell lung cancer and from hea...
What is the current status of trial NCT00897234?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2008-12. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00897234?
The interventions under investigation include: Mass Spectrometry (OTHER).
Who is sponsoring clinical trial NCT00897234?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia